MedTrace Logo

Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use

NCT02200666 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7793

Last updated 2020-02-25

No results posted yet for this study

Summary

The purpose of the investigation is to confirm the following under the post-marketing actual use of Forxiga Tablets (hereinafter referred to as Forxiga)

* Development of ADRs specified as Key Investigation Items and the risk factors
* Contributing factors possibly having an impact on the safety and efficacy
* Development of ADRs unexpected from the Precautions for use and ADRs under actual drug use

Conditions

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-03
Primary Completion
2019-09-09
Completion
2019-09-09

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02200666 on ClinicalTrials.gov